CLINICAL_TRIALS
trial_result
· 2007-03-05
Clinical Trial Update: Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer [Phase 2]
Summary
A Phase 2 study of motexafin gadolinium for renal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pharmacyclics LLC. | Conditions: Carcinoma, Renal Cell, Urogenital Neoplasms | Phase 2 | Status: COMPLETED